nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicergoline—ADRA1A—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.119	0.136	CbGpPWpGaD
Nicergoline—Methysergide—HTR1B—attention deficit hyperactivity disorder	0.0839	0.658	CrCbGaD
Nicergoline—ADRA1A—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0623	0.0715	CbGpPWpGaD
Nicergoline—Methysergide—HTR2A—attention deficit hyperactivity disorder	0.0436	0.342	CrCbGaD
Nicergoline—ADRA1A—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.042	0.0481	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0411	0.0471	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0353	0.0404	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0346	0.0396	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0249	0.0286	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.024	0.0275	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0232	0.0265	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0224	0.0257	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.022	0.0253	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0218	0.025	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0209	0.024	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0203	0.0233	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0195	0.0223	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0189	0.0216	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0185	0.0212	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0183	0.021	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0171	0.0195	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0142	0.0163	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0119	0.0137	CbGpPWpGaD
Nicergoline—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0117	0.0134	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0081	0.00928	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00794	0.0091	CbGpPWpGaD
Nicergoline—ADRA1A—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00793	0.00909	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00788	0.00903	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00694	0.00795	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0068	0.00779	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0055	0.0063	CbGpPWpGaD
Nicergoline—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0053	0.00608	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00528	0.00606	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00518	0.00593	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00481	0.00551	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00471	0.0054	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00447	0.00512	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00445	0.0051	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00433	0.00496	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00426	0.00488	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0042	0.00482	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00412	0.00472	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00404	0.00463	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00392	0.00449	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00383	0.00439	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00371	0.00425	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00365	0.00418	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0036	0.00413	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00359	0.00411	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00355	0.00407	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00335	0.00384	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00317	0.00364	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00314	0.0036	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00299	0.00342	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00293	0.00335	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00292	0.00334	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00284	0.00325	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00282	0.00324	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00282	0.00323	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0028	0.00321	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00278	0.00318	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00274	0.00314	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00274	0.00314	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00271	0.00311	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00266	0.00305	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00255	0.00293	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00239	0.00274	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00235	0.00269	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00203	0.00232	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00186	0.00214	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00184	0.00211	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00179	0.00205	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00177	0.00203	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00165	0.00189	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00161	0.00184	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.0016	0.00184	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.0016	0.00183	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00157	0.0018	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00157	0.0018	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00155	0.00178	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00154	0.00176	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0015	0.00172	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00145	0.00166	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00144	0.00165	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00142	0.00163	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00141	0.00161	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00131	0.0015	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00116	0.00133	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00109	0.00125	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00101	0.00116	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000951	0.00109	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000918	0.00105	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000884	0.00101	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000856	0.000981	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000842	0.000965	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000831	0.000953	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000801	0.000918	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000801	0.000918	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000788	0.000903	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000774	0.000887	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000732	0.000839	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00064	0.000734	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000609	0.000698	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000542	0.000622	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000485	0.000556	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000482	0.000552	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000287	0.000329	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000208	0.000238	CbGpPWpGaD
